CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Real-world evidence on all-oral, interferon-free regimens with Ombitasvir/Paritaprevir/r and Dasabuvir for treatment of chronic HCV patients receiving opioid substitution therapy in the German Hepatitis C-Registry
DOI 10.1055/s-0036-1597419
Bibliografische Angaben
Nachweis in CareLit
Autor:innenS Christensen, H Wedemeyer, P Buggisch, NE Lyonn, P Khaykin, A Schober, T Lutz, G Teuber, S Mauss, B König, J Hettinger
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe12/2016
Jahrgang / SeitenJg. 54
Kernaussage aus der Literatur
Abstract-Vorschau
Real-world evidence on all-oral, interferon-free regimens with Ombitasvir/Paritaprevir/r and Dasabuvir for treatment of chronic HCV patients receiving opioid substitution therapy in the German Hepatitis C-Registry
Zitieren
Zitierempfehlung
S Christensen, H Wedemeyer, P Buggisch, NE Lyonn, P Khaykin, A Schober, T Lutz, G Teuber, S Mauss, B König, J Hettinger (2016) Real-world evidence on all-oral, interferon-free regimens with Ombitasvir/Paritaprevir/r and Dasabuvir for treatment of chronic HCV patients receiving opioid substitution therapy in the German Hepatitis C-Registry. Zeitschrift für Gastroenterologie, 54 (12). https://doi.org/10.1055/s-0036-1597419
Mit CareLit weiterarbeiten